On May 5th, the 2023 7th Top 100 Future Healthcare Conference was held in Shanghai with the theme of "Young Forever". And "2023 Future Medical Top 100 Growth Analysis Report". Shanghai Bangbang Robotics Co.,Ltd participated in the conference as the top 100 winners in the future medical care list. It profoundly interpreted the forward spirit of medical innovation pioneers, upholding the original intention of "respecting life", actively and courageously shouldering the important task of industrial transformation.

Shanghai Bangbang Robotics Co.,Ltd was established in 2016 and headquartered in Shanghai. It is committed to the cutting-edge development needs of the assisted travel track in the medical industry, focusing on the core needs of the elderly and people with lower limb disabilities, and in-depth knowledge of the world's leading new generation of assisted travel and rehabilitation training robots. Independent R&D and cutting-edge research in the field of information provide intelligent solutions.

The Top 100 List of Future Medical Care is the first domestic list of innovative medical care for non-listed companies launched by VB100, Arterial Network, and Eggshell Research Institute. It aims to select Chinese innovative medical practitioners who truly represent the future of medical care and discover the future of my country. The core strength of the medical industry, promoting the innovation and transformation process of the health care industry.

"In 2017, Robooter was the first domestic home intelligent rehabilitation robot. Over the years, Robooter's intelligent assisted travel and life assistance products have also entered people's lives and brought new life experience. Now, Robooter is in the whole The domestic market share has reached 25%, and in the international market, it has also been exported to more than 20 countries." Mr. Li Jianguo, the founder and CEO of Shanghai Bangbang Robotics Co.,Ltd, mentioned in the interview.

From rehabilitation training to assisted travel, the application scene has expanded from indoors to outdoors. From being based in China to going global, Robooter has continuously improved the product matrix and formed a full-scenario product with "travel" as the core point, radiating rehabilitation training and life assistance. Line layout, focusing on the "product + platform + service" model, based on technology leading strategy, scenario ecological strategy, high service and globalization strategy, to achieve high-speed and high-quality development.

The three representative smart products that have been launched successively have excellently met the expectations of "smart services + active safety protection + multi-environmental adaptability" for groups with travel difficulties. The birth of Robooter intelligent assisted mobile robot has broadened the application boundary of intelligent rehabilitation training, so that it can be better applied to social organization units such as communities and families, and comprehensively reduce the rehabilitation cost of required personnel. Consumer-grade mobility robots enjoy the Robooter X series and Robooter E series, which apply more Internet and AI technologies to establish information sharing and device interconnection at the user end and family end, forming a smart IoT life that integrates users, products, and family members. Experience, and provide users with super-imaginative services in more scenarios such as cruise control, novice mode, automatic driving, and remote after-sales, making assisted travel safer, more convenient, more comfortable, and more fun. Among them, the new product Yuexiang E series made its global debut in April this year.

In fact, as a new innovative force in the assisted travel and medical device industry, Robooter has been promoting the development of the entire industry. In June 2017, Robooter released an intelligent auxiliary mobile robot, which is the first rear-mounted standing robot in China. In December 2018, robooter electric lift was selected into the "Innovative Medical and Device Product Catalog (2018)" by the Ministry of Science and Technology, which is the first in China. From June to September 2019, he took the lead in formulating the group standard of "Intelligent Electric Lifting Vehicle" and won the China Standard Innovation Contribution Award. At the same time, he also participated in the formulation of the national standard for the new category of robotic wheelchair in the Japanese medical care catalog, which not only solved the problem of the industry The fact that there are no standards to follow has also enhanced the international credibility of my country's intelligent electric lifts and wheelchair products. In October 2020, Robooter released the representative product of the mobility robot, the Honor Robooter X40, breaking the long-term dependence on imports of high-end electric mobility aids in China.

This selection is based on the VB100 value evaluation model, through the process of self-declaration by the enterprise, review by the VB100 review meeting, cross-review by supporting institutions, and final review by the expert committee. Supply Chain Services) to select the innovative enterprises with the valuation ranking TOP100. In addition to the valuation, the growth and annual performance of candidate companies will be supplemented with four primary indicators of human resources, knowledge resources, important partner resources, and market performance, and a total of 17 secondary indicators.

In July 2022, Shanghai Bangbang Robotics Co.,Ltd announced the completion of the B-round financing of nearly 100 million yuan. The first-line medical fund Lake Bleu Capital and BioTrack Capital jointly led the investment, Zero One Venture Capital followed the investment, and the old shareholder Long Hill Capital continued to follow the investment. Haoyue Capital Served as the exclusive financial advisor for the financing. At present, the core team of Shanghai Bangbang Robotics Co., Ltd. is composed of senior practitioners in the medical device and intelligent robot industries and an expert team with an international background. The profound technical accumulation, innovation ability and efficient execution highlight the strong development resilience. The valuation of VB100 has reached 1.752 billion.

The strong listing this time is the recognition of Robooter by the authoritative field and the market, and it is also a powerful interpretation of Robooter's innovative influence. In the future, Shanghai Bangbang Robotics Co.,Ltd will continue to focus on user needs and continue to optimize products, use technological innovation strength to create travel-assisted robot products that better meet user needs, and strive to improve the quality of life for users with travel disabilities.